Fluoroquinolone- resistant typhoid, South Africa

Emerging Infectious Diseases

Volumn 16, Issue 5, 2010, Pages 879-880

  Keddy, Karen H ^a,b   Smith, Anthony M ^a,b   Sooka, Arvinda ^a   Ismail, Husna ^a,b   Oliver, Stephen ^c,d  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE (ATP HYDROLYSING) B; DOXYCYCLINE; NALIDIXIC ACID; PROTEIN PARC; PROTEIN PARE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFAMETHOXAZOLE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; BLOOD CULTURE; DISEASE TRANSMISSION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENDEMIC DISEASE; GENE MUTATION; GENE SEQUENCE; HUMAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; NUCLEOTIDE SEQUENCE; PULSED FIELD GEL ELECTROPHORESIS; SALMONELLA ENTERICA; SEROTYPE; SOUTH AFRICA; TYPHOID FEVER;

AGED; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FEMALE; GENES, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION, MISSENSE; PHYLOGENY; SALMONELLA TYPHI; SOUTH AFRICA; TYPHOID FEVER;

EID: 77951182004     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1605.091917     Document Type: Letter

References (10)

1. Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Organ. 2004;82:346-53.
2. Group for Enteric Respiratory and Meningeal Disease Surveillance in South Africa. GERMS-SA Annual Report 2008. 2009 [cited 2010 Mar 9]. http://www.nicd. ac.za/units/germs/annual/germssa_ann_ report_2008.pdf
3. World Health Organization. Background document: the diagnosis, treatment and prevention of typhoid fever. Geneva: The Organization, 2003.
4. Kubota K, Barrett TJ, Ackers ML, Brachman PS, Mintz ED. Analysis of Salmonella enterica serotype Typhi pulsed-fi eld gel electrophoresis patterns associated with international travel. J Clin Microbiol. 2005;43:1205-9. DOI: 10.1128/JCM.43.3.1205-1209.2005
5. Ribot EM, Fair MA, Gautom R, Cameron DN, Hunter SB, Swaminathan B, et al. Standardization of pulsed-fi eld gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis. 2006;3:59-67. DOI: 10.1089/ fpd.2006.3.59
6. Smith AM, Govender N, Keddy KH. Quinolone-resistant Salmonella Typhi in South Africa, 2003-2007. Epidemiol Infect. 2010;138:86-90. DOI: 10.1017/ S0950268809990331
7. Hirose K, Hashimoto A, Tamura K, Kawamura Y, Ezaki T, Sagara H, et al. DNA sequence analysis of DNA gyrase and DNA topoisomerase IV quinolone resistance- determining regions of Salmonella enterica serovar typhi and serovar paratyphi A. Antimicrob Agents Chemother. 2002;46:3249-52. DOI: 10.1128/ AAC.46.10.3249-3252.2002
8. Gunell M, Webber MA, Kotilainen P, Lilly AJ, Caddick JM, Jalava J, et al. Mechanisms of resistance in nontyphoidal Salmonella enterica strains exhibiting a nonclassical quinolone resistance phenotype. Antimicrob Agents Chemother. 2009;53:3832-6. DOI: 10.1128/ AAC.00121-09
9. Pfeifer Y, Matten J, Rabsch W. Salmonella enterica serovar Typhi with CTX-M beta-lactamase, Germany. Emerg Infect Dis. 2009;15:1533-5. DOI: 10.3201/ eid1509.090567
10. Ackers ML, Puhr ND, Tauxe RV, Mintz ED. Laboratory-based surveillance of Salmonella serotype Typhi infections in the United States: antimicrobial resistance on the rise. JAMA. 2000;283:2668-73. DOI: 10.1001/jama.283.20.2668